194例HBeAg阳性乙肝病毒携带者中医证候分型研究

来源 :第二十三次全国中西医结合肝病学术会议 | 被引量 : 0次 | 上传用户:iuonake5
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的:观察HBeAg阳性的乙肝病毒携带者中医证候分型,为临床对本病的防治提供依据.方法:将194例HBeAg阳性的乙肝病毒携带者,根据慢性乙肝病毒携带者证候规律研究的病例报告表(CRF)进行问卷调查,将HBeAg阳性乙肝病毒携带者的问卷调查中症状专家辨证结果进行分析研究.结果:194例HBeAg阳性的乙肝病毒携带者涉及的中医证型有9种,9种证型及出现频数所占百分比分别为:肾虚(35.1%)、脾虚(11.3%)、肝气郁结(8.2%)、肝阴虚(6.2%)、肝胃不和(5.7%)、肝胆湿热(3.6%)、肝血虚(2.1%)、湿困中焦(2.1%)、湿热中阻(2.1%).其中无证可辨(39.7%)及兼夹证型(13.9%)亦占了较大比例,兼夹证型以肝胆湿热和湿热中阻为主,无证可辨经中医体质分型主要集中在肾虚质、气虚质及气郁质.结论:HBeAg阳性的乙肝病毒携带者中医证候分型以肾虚、脾虚、肝气郁结等较为多见.
其他文献
Stel B (Stellettin B) was isolated from marine sponge Jaspis stellifera.In vitro antitumor activities were investigated on 39 human cancer cell lines (JFCR39).Stel B exhibited highly potent inhibition
As accumulating evidences suggest close involvement of phosphatidylinositol 3-kinase (PI3K) in cancer, novel PI3K inhibitors such as ZSTK474, GDC-0941,NVP-BEZ235 and BKM-120 have been developed for ca
会议
会议
Aim: We sought to determine the relationship between cancer-related fatigue,chemotherapy-associated adverse effects in patients with advanced stages of cancer,and the levels ofTNF-a, IL-1 and 17-hydro
会议
Purpose: To investigate the mechanism of pretreatment with EGFR inhibitors sensitizes cancer cells to DNA-damaging therapy.Implementation &Methodology: MTT assay was applyed to detect inhibition of ce
会议
Objective: To observe the changes of mitochondrial membrane potential (MMP),cytochrome c (Cyto-c), Caspase-3, 9 activity, cleavage of PARP and phosphorylation level of AKT and ERK, investigate the mec
会议
会议
Purpose: Numb is evolutionary conserved from Drosophila to human, and considered as the cell fate determination protein by being asymmetrically segregated during cell division.Mammalian Numb (mNumb) d
会议
会议